Skip to main content
. 2016 Jun 29;6:28978. doi: 10.1038/srep28978

Figure 2. The antiviral activity of CypA transgenic mice, as evaluated by influenza infection at various doses.

Figure 2

Wild type, CypA-CMV, and -SPC over-expressing C57BL/6 mice were inoculated i.n. with WSN at doses of 1000 (A), 2000 (B), 4000 (C), and 8000 PFU (D), respectively (n = 5 per dilution, 20 mice per group). The mice in the control group were i.n. inoculated with PBS for mock infection. The body weights of five mice in each group were monitored daily for 14 days and are expressed as a percentage of the initial value. The data represents the mean of five mice in each group.